Cargando…
CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
Glioma is the most malignant cancer of the central nervous system. There are various therapies for treating gliomas, but their outcomes are not satisfactory. Therefore, new targets for glioma treatment are needed. This study examined the cadherin-6 (CDH6) expression in gliomas using The Cancer Genom...
Autores principales: | Meng, Ming, Zhou, Hongshu, He, Ye, Chen, Lu, Wang, Wanpeng, Yang, Liting, Wang, Zeyu, Zhang, Liyang, Wang, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355303/ https://www.ncbi.nlm.nih.gov/pubmed/35938030 http://dx.doi.org/10.3389/fgene.2022.949552 |
Ejemplares similares
-
The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment
por: Zhou, Hongshu, et al.
Publicado: (2022) -
Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment
por: Chen, Bo, et al.
Publicado: (2022) -
Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma
por: Lv, Liting, et al.
Publicado: (2020) -
Prognostic Roles of Central Carbon Metabolism–Associated Genes in Patients With Low-Grade Glioma
por: Wang, Li, et al.
Publicado: (2019) -
MiR-33a targets FOSL1 and EN2 as a clinical prognostic marker for sarcopenia by glioma
por: Wang, Wei, et al.
Publicado: (2022)